LIN vs YCBD · P/E 34, rev $18.07B vs P/E 0.3, rev $19.5M
Linde plc Ordinary Shares (LIN) versus cbdMD Inc (YCBD) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
cbdMD Inc (YCBD) is a drug manufacturers - specialty & generic company listed on AMEX.
Latest reported LIN revenue for 2026-06-30 was $18.07B. Net income was $3.79B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported YCBD revenue for 2024-09-30 was $19.5M. Net income was -$152.8K. Revenue was down 19.3% from 2023-09-30 to 2024-09-30. YCBD currently screens at market cap $7.2M and trailing P/E 0.3.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. YCBD currently screens at market cap $7.2M and trailing P/E 0.3.
Not investment advice. Open the LIN and YCBD stock pages for the full models.
Not investment advice.